Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Talimogene laherparepvec (formerly OncoVEX GM-CSF)
print preview
bookmark
share with colleague
General Information
Company
Amgen Inc.
Description
Modified herpes simplex virus type 1 (HSV-1) encoding GM-CSF
Molecular Target
Mechanism of Action
Oncolytic virus
Latest Stage of Development
Phase III
Indication
Melanoma
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy